182 related articles for article (PubMed ID: 19752236)
1. A novel role for plasmin-mediated degradation of opsonizing antibody in the evasion of host immunity by virulent, but not attenuated, Francisella tularensis.
Crane DD; Warner SL; Bosio CM
J Immunol; 2009 Oct; 183(7):4593-600. PubMed ID: 19752236
[TBL] [Abstract][Full Text] [Related]
2. IFN-β mediates suppression of IL-12p40 in human dendritic cells following infection with virulent Francisella tularensis.
Bauler TJ; Chase JC; Bosio CM
J Immunol; 2011 Aug; 187(4):1845-55. PubMed ID: 21753150
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.
Skyberg JA; Rollins MF; Samuel JW; Sutherland MD; Belisle JT; Pascual DW
Infect Immun; 2013 Sep; 81(9):3099-105. PubMed ID: 23774604
[TBL] [Abstract][Full Text] [Related]
4. Detrimental Influence of Alveolar Macrophages on Protective Humoral Immunity during Francisella tularensis SchuS4 Pulmonary Infection.
Steiner DJ; Furuya Y; Metzger DW
Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29311236
[TBL] [Abstract][Full Text] [Related]
5. Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity.
Okan NA; Chalabaev S; Kim TH; Fink A; Ross RA; Kasper DL
mBio; 2013 Feb; 4(1):e00638-12. PubMed ID: 23404403
[TBL] [Abstract][Full Text] [Related]
6. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.
Bakshi CS; Malik M; Mahawar M; Kirimanjeswara GS; Hazlett KR; Palmer LE; Furie MB; Singh R; Melendez JA; Sellati TJ; Metzger DW
Vaccine; 2008 Sep; 26(41):5276-88. PubMed ID: 18692537
[TBL] [Abstract][Full Text] [Related]
7. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
Kubelkova K; Krocova Z; Balonova L; Pejchal J; Stulik J; Macela A
Microb Pathog; 2012; 53(5-6):259-68. PubMed ID: 22841607
[TBL] [Abstract][Full Text] [Related]
8. Fine tuning inflammation at the front door: macrophage complement receptor 3-mediates phagocytosis and immune suppression for Francisella tularensis.
Dai S; Rajaram MV; Curry HM; Leander R; Schlesinger LS
PLoS Pathog; 2013 Jan; 9(1):e1003114. PubMed ID: 23359218
[TBL] [Abstract][Full Text] [Related]
9. The presence of CD14 overcomes evasion of innate immune responses by virulent Francisella tularensis in human dendritic cells in vitro and pulmonary cells in vivo.
Chase JC; Bosio CM
Infect Immun; 2010 Jan; 78(1):154-67. PubMed ID: 19841074
[TBL] [Abstract][Full Text] [Related]
10. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.
Jia Q; Lee BY; Bowen R; Dillon BJ; Som SM; Horwitz MA
Infect Immun; 2010 Oct; 78(10):4341-55. PubMed ID: 20643859
[TBL] [Abstract][Full Text] [Related]
11. Alternative activation of macrophages and induction of arginase are not components of pathogenesis mediated by Francisella species.
Griffin AJ; Crane DD; Wehrly TD; Scott DP; Bosio CM
PLoS One; 2013; 8(12):e82096. PubMed ID: 24324751
[TBL] [Abstract][Full Text] [Related]
12. Genetic modification of the O-polysaccharide of Francisella tularensis results in an avirulent live attenuated vaccine.
Kim TH; Pinkham JT; Heninger SJ; Chalabaev S; Kasper DL
J Infect Dis; 2012 Apr; 205(7):1056-65. PubMed ID: 21969334
[TBL] [Abstract][Full Text] [Related]
13. Identification of a live attenuated vaccine candidate for tularemia prophylaxis.
Mahawar M; Rabadi SM; Banik S; Catlett SV; Metzger DW; Malik M; Bakshi CS
PLoS One; 2013; 8(4):e61539. PubMed ID: 23613871
[TBL] [Abstract][Full Text] [Related]
14. Role of peroxiredoxin of the AhpC/TSA family in antioxidant defense mechanisms of Francisella tularensis.
Alharbi A; Rabadi SM; Alqahtani M; Marghani D; Worden M; Ma Z; Malik M; Bakshi CS
PLoS One; 2019; 14(3):e0213699. PubMed ID: 30870480
[TBL] [Abstract][Full Text] [Related]
15. Low dose vaccination with attenuated Francisella tularensis strain SchuS4 mutants protects against tularemia independent of the route of vaccination.
Rockx-Brouwer D; Chong A; Wehrly TD; Child R; Crane DD; Celli J; Bosio CM
PLoS One; 2012; 7(5):e37752. PubMed ID: 22662210
[TBL] [Abstract][Full Text] [Related]
16. Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization.
Conlan JW; Shen H; Golovliov I; Zingmark C; Oyston PC; Chen W; House RV; Sjöstedt A
Vaccine; 2010 Feb; 28(7):1824-31. PubMed ID: 20018266
[TBL] [Abstract][Full Text] [Related]
17. B1a cells enhance susceptibility to infection with virulent Francisella tularensis via modulation of NK/NKT cell responses.
Crane DD; Griffin AJ; Wehrly TD; Bosio CM
J Immunol; 2013 Mar; 190(6):2756-66. PubMed ID: 23378429
[TBL] [Abstract][Full Text] [Related]
18. Francisella tularensis SchuS4 and SchuS4 lipids inhibit IL-12p40 in primary human dendritic cells by inhibition of IRF1 and IRF8.
Ireland R; Wang R; Alinger JB; Small P; Bosio CM
J Immunol; 2013 Aug; 191(3):1276-86. PubMed ID: 23817430
[TBL] [Abstract][Full Text] [Related]
19. The role of complement opsonization in interactions between F. tularensis subsp. novicida and human neutrophils.
Barker JH; McCaffrey RL; Baman NK; Allen LA; Weiss JP; Nauseef WM
Microbes Infect; 2009; 11(8-9):762-9. PubMed ID: 19409509
[TBL] [Abstract][Full Text] [Related]
20. Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia.
Hickey AJ; Hazlett KR; Kirimanjeswara GS; Metzger DW
Vaccine; 2011 Sep; 29(40):6941-7. PubMed ID: 21803089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
